Abiopharma

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Moshkevich Solomon adjusted position in 800.0 shares of Natera, Inc. (NTRA) at average price $155.46 Filed: 2025-08-15 AccNo: 0001415889-25-022148 Size: 8 KB

4 - Moshkevich Solomon (0002010019) (Reporting)

4 - Fesko John (0002010135) (Reporting)

New Form 144 - BIOLIFE SOLUTIONS INC Filed: 2025-08-15 AccNo: 0000919574-25-004980 Size: 7 KB

144 - Casdin Partners Master Fund, L.P. (0001534265) (Reporting)

New Form SCHEDULE 13D/A - HENRY SCHEIN INC Filed: 2025-08-15 AccNo: 0001140361-25-031604 Size: 764 KB

SCHEDULE 13D/A - KKR Hawaii Aggregator L.P. (0002060445) (Filed by)

New Form 3 - HENRY SCHEIN INC Filed: 2025-08-15 AccNo: 0001140361-25-031603 Size: 13 KB

SCHEDULE 13D/A - MERCURY SYSTEMS INC (0001049521) (Subject)

SCHEDULE 13D/A - JANA Partners Management, LP (0001998597) (Filed by)

New Form 3 - USBC, Inc. Filed: 2025-08-15 AccNo: 0001161697-25-000279 Size: 3 KB

3 - KKR Hawaii Holdings L.P. (0002072003) (Reporting)